No credit card. No commitment.
5000+ G2 reviews
Entos Pharmaceuticals
Biotechnology
Founded in 2016
Edmonton, AlbertaEntos Pharmaceuticals
BiotechnologyFounded in 2016Edmonton, Alberta
EmployeesEntos Pharmaceuticals' financial review
Entos Pharmaceuticals' Revenue (Yearly)
4.3M
Employees
50
Entos Pharmaceuticals information
Entos Pharmaceuticals Inc. is a clinical-stage genetic medicines company. A new reality in genetic medicine lies ahead, one that will be ushered in with the advent of safe, effective, and redosable nucleic acid delivery technologies. At Entos, we develop next generation genetic medicines using our proprietary Fusogenix proteolipid vehicle (PLV) drug delivery system. Fusogenix PLVs are formulated w...
Entos Pharmaceuticals Inc. is a clinical-stage genetic medicines company. A new reality in genetic medicine lies ahead, one that will be ushered in with the advent of safe, effective, and redosable nucleic acid delivery technologies. At Entos, we develop next generation genetic medicines using our proprietary Fusogenix proteolipid vehicle (PLV) drug delivery system. Fusogenix PLVs are formulated with FAST proteins to enable the delivery of nucleic acid into target cells through direct fusion.
Entos Pharmaceuticals industries
Genetic medicine
Proteolipid vehicles
Drug delivery
Redosable
Entos Pharmaceuticals' financial review
Entos Pharmaceuticals' Revenue (Yearly)
4.3M
Employees
50
Employee Metrics
Technologies
Email Providers
Other
Other
Hosting
CMS
Other
Notable Alumni
Employees
Research Assistant
Associate Scientist
Lead Scientist II - Innovation in Biochemistry
PhD (Chemistry)
Prospect on LinkedIn
Find verified emails and direct dial mobile numbers of contacts on LinkedIn, and sync them with your CRM instantly
Download Extension
Why our clients choose Apollo
“Apollo completely changed the game for us. It allowed us to identify relevant targets that are ready to scale and reach out to them at the exact right time.”
Erik Straub
Head of Product, Kickfurther
“Using Apollo.io, we've solved the biggest problem for every business, the lead problem. We are now constrained by sales time and no longer lack interested prospects.”
Michael Transon
CEO, Victorious
